NIH launches major study to uncover why rheumatic diseases hit minorities harder

NCT ID NCT00024479

First seen Jun 26, 2026 · Last updated Aug 05, 2026 · Updated 11 times

Summary

This study aims to learn more about the causes of rheumatic diseases—conditions that cause joint pain, stiffness, and swelling—and why they often affect minority groups more severely. Researchers will observe up to 7,500 adults with known or suspected rheumatic disease, providing standard medical care and collecting data through routine tests and imaging. No experimental treatments are involved; the goal is to gather information to design better future studies and address health disparities.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to
If successful, this study could help researchers understand why rheumatic diseases affect minority communities more severely and guide future targeted research.
What could go wrong
This is an observational study with no experimental treatment, so it will not directly improve symptoms or provide a cure. Results may take years to inform new therapies.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ARTHRITIS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • National Institutes of Health Clinical Center

    RECRUITING

    Bethesda, Maryland, 20892, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.